Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis

Diffuse alveolar hemorrhage (DAH) syndrome is characterized by bleeding into the alveolar spaces of the lungs and occurs when there is an injury to the alveolar microcirculation that leads to hemorrhage from the alveolar capillaries. We report a case of an 82-year-old woman who presented with acute...

Full description

Bibliographic Details
Main Authors: Ahmad Assad MD, Mohammad Alkhaldi MD, Andrew Abrahamian MD, Brandon Yonel MD, Ragheb Assaly MD, Nazem Altorok MD
Format: Article
Language:English
Published: SAGE Publishing 2023-08-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096231196698
_version_ 1797730129389027328
author Ahmad Assad MD
Mohammad Alkhaldi MD
Andrew Abrahamian MD
Brandon Yonel MD
Ragheb Assaly MD
Nazem Altorok MD
author_facet Ahmad Assad MD
Mohammad Alkhaldi MD
Andrew Abrahamian MD
Brandon Yonel MD
Ragheb Assaly MD
Nazem Altorok MD
author_sort Ahmad Assad MD
collection DOAJ
description Diffuse alveolar hemorrhage (DAH) syndrome is characterized by bleeding into the alveolar spaces of the lungs and occurs when there is an injury to the alveolar microcirculation that leads to hemorrhage from the alveolar capillaries. We report a case of an 82-year-old woman who presented with acute respiratory distress. The patient had a history of rheumatoid arthritis (RA) and was on amiodarone for atrial fibrillation therapy. Initial diagnostic workup, including bronchoscopy and imaging studies, revealed diffuse opacities and the bronchoalveolar lavage fluid consistent with DAH. The patient required aggressive management with supportive care and corticosteroids. Laboratory work showed a synergistic effect between amiodarone and RA in inducing DAH. This makes the report unique as no reports in the literature described a synergic effect of amiodarone and RA in inducing DAH. The primary objective of this report is to guide physicians and remind them to keep DAH at the top of their differential diagnosis in the setting of an RA patient taking amiodarone.
first_indexed 2024-03-12T11:39:47Z
format Article
id doaj.art-98da96a0451c40b189de4b58d2c4d8ef
institution Directory Open Access Journal
issn 2324-7096
language English
last_indexed 2024-03-12T11:39:47Z
publishDate 2023-08-01
publisher SAGE Publishing
record_format Article
series Journal of Investigative Medicine High Impact Case Reports
spelling doaj.art-98da96a0451c40b189de4b58d2c4d8ef2023-08-31T17:33:47ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962023-08-011110.1177/23247096231196698Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid ArthritisAhmad Assad MD0Mohammad Alkhaldi MD1Andrew Abrahamian MD2Brandon Yonel MD3Ragheb Assaly MD4Nazem Altorok MD5The University of Jordan, Amman, JordanJordan University of Science and Technology, Irbid, JordanThe University of Toledo, OH, USAThe University of Toledo, OH, USAThe University of Toledo, OH, USAThe University of Toledo, OH, USADiffuse alveolar hemorrhage (DAH) syndrome is characterized by bleeding into the alveolar spaces of the lungs and occurs when there is an injury to the alveolar microcirculation that leads to hemorrhage from the alveolar capillaries. We report a case of an 82-year-old woman who presented with acute respiratory distress. The patient had a history of rheumatoid arthritis (RA) and was on amiodarone for atrial fibrillation therapy. Initial diagnostic workup, including bronchoscopy and imaging studies, revealed diffuse opacities and the bronchoalveolar lavage fluid consistent with DAH. The patient required aggressive management with supportive care and corticosteroids. Laboratory work showed a synergistic effect between amiodarone and RA in inducing DAH. This makes the report unique as no reports in the literature described a synergic effect of amiodarone and RA in inducing DAH. The primary objective of this report is to guide physicians and remind them to keep DAH at the top of their differential diagnosis in the setting of an RA patient taking amiodarone.https://doi.org/10.1177/23247096231196698
spellingShingle Ahmad Assad MD
Mohammad Alkhaldi MD
Andrew Abrahamian MD
Brandon Yonel MD
Ragheb Assaly MD
Nazem Altorok MD
Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
Journal of Investigative Medicine High Impact Case Reports
title Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
title_full Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
title_fullStr Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
title_full_unstemmed Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
title_short Diffuse Alveolar Hemorrhage Synergistically Induced by Amiodarone and Rheumatoid Arthritis
title_sort diffuse alveolar hemorrhage synergistically induced by amiodarone and rheumatoid arthritis
url https://doi.org/10.1177/23247096231196698
work_keys_str_mv AT ahmadassadmd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis
AT mohammadalkhaldimd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis
AT andrewabrahamianmd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis
AT brandonyonelmd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis
AT raghebassalymd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis
AT nazemaltorokmd diffusealveolarhemorrhagesynergisticallyinducedbyamiodaroneandrheumatoidarthritis